Global
US
Global
中文
繁体
Home
BeiGene
Main navigation
About
Our Story
Leadership Team
Meet More of Our Team
Focus on Quality
Who We Are
Ethics
Science & Pipeline
Research & Development
Manufacturing
Pipeline
Zanubrutinib
Tislelizumab
Pamiparib
Lifirafenib
Preclinical Candidates
Partnering
Partnering with BeiGene
Doing Business in China
BeiGene
Patients
Clinical Trials
Access to Investigational Medicines
Careers
Culture & Benefits
Job Opportunities
Investors
NASDAQ Investors
HKEX Investors
Investors Overview
Corporate Governance
Listing Documents
Stock Information
Stock Chart
Analyst Coverage
Financial Report
Investor Presentation
Investor Video
Email Alerts
HKEX Announcements
Circular
Press Release
Event Calendar
BeiGene to Host Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research
BeiGene at Goldman Sachs 41st Annual Global Healthcare Conference
BeiGene to Discuss Clinical Study Results Presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
BeiGene at Cowen and Company's 40th Annual Health Care Conference
BeiGene to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
BeiGene at the Piper Sandler 32nd Annual Virtual Healthcare Conference
BeiGene 2020 China National Reimbursement Drug List (NRDL) Results Conference Call
BeiGene to Present at the J.P. Morgan 39th Annual Healthcare Conference
IR Contact
Media
Contact
HKEX Investor Relations
Investors Overview
Corporate Governance
Listing Documents
Stock Information
Stock Chart
Analyst Coverage
Financial Report
Investor Presentation
Investor Video
Email Alerts
HKEX Announcements
Circular
Press Release
Event Calendar
IR Contact
BeiGene at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Monday, Nov 23 - Thursday, Dec 3, 2020
Click here for webcast